BioPorto CEO explains why he's expecting 2021 to be a 'pivotal year - Peter Mørch Eriksen, CEO/Board Member,Bioporto 00:00:00
Peter Mørch Eriksen was appointed CEO effective January 9, 2024. Mr. Eriksen served as CEO of BioPorto from 2013 – 2021. He has spent more than 20 years in the MedTech/life science industries, including as CEO of Sense A/S and VP of Medtronic. From these positions, Mr. Eriksen has extensive experience in creating growth, restructuring and funding in technology-intensive and complex companies.